Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2008
10/28/2008US7442534 Nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
10/28/2008US7442532 Essential fungal CaYLR100w polypeptides, and methods of use
10/28/2008US7442526 co-expressing bicistronically caspase 4 with the human precursor IL-18 polypeptide and purifying the active polypeptide
10/28/2008US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia
10/28/2008US7442523 Nucleotide sequences coding bacterial surface protein for use in development of vaccines and prevention of infection
10/28/2008US7442522 Nucleic acids encoding chromo or fluorescent proteins and method for using the same
10/28/2008US7442521 To generate transgenic, non-human plants or animals or site specific gene modifications in cell lines; fluorescent proteins high through-put screening assays; use as biosensors in prokaryotic and eukaryotic cells, fluorescence activated cell sorting applications, as markers following injection into cells
10/28/2008US7442520 modulator of tumor growth and metastasis in certain cancer types, especially breast and lung cancer
10/28/2008US7442512 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
10/28/2008US7442504 Detecting an elite event EE-GH1 specific region with a primer or probe; amplifying DNA; kits; optimal agronomic performance
10/28/2008US7442381 Alphavirus replicons and helper constructs
10/28/2008US7442379 Recombinant Newcastle disease virus RNA expression systems and vaccines
10/28/2008US7442378 Having mutation in viral nucleic acid encoding viral protein 2; bird and chicken vaccines
10/28/2008US7442376 Glycoprotein hormone compositions containing two β subunits
10/28/2008US7442371 Recombinant human albumin-erythropoietin fusion proteins with long-lasting biological effects
10/28/2008US7442370 Polymer conjugates of mutated neublastin
10/28/2008US7442308 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process
10/28/2008CA2367003C Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same
10/28/2008CA2304130C Novel fas ligand derivative
10/28/2008CA2263797C Methods for modulating seed mass by expression of a nucleic acid containing an ap2 domain
10/28/2008CA2236948C Modified proteins and methods of their production
10/28/2008CA2235805C Anti-cancer agent
10/28/2008CA2225924C Recombinant mistletoe lectin
10/28/2008CA2074355C Method of producing fertile transgenic corn plants
10/27/2008CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions
10/23/2008WO2008128103A1 A novel gene associated with fragile x syndrome and fragile x tremor ataxia syndrome
10/23/2008WO2008128100A1 Small-molecule inhibitors of the androgen receptor
10/23/2008WO2008128089A1 Use of substrates as pharmacological chaperones
10/23/2008WO2008127973A1 Cd161 ligand, pilar, for modulating activation and proliferation of t cells
10/23/2008WO2008127711A2 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008WO2008127702A2 Modified factor vii polypetides and uses thereof
10/23/2008WO2008127680A2 Diagnosis and treatment of diseases caused by misfolded proteins
10/23/2008WO2008127450A2 Linear expression cassette vaccines
10/23/2008WO2008127271A2 Interleukin -13 binding proteins
10/23/2008WO2008127180A1 Use of selected lactic acid bacteria for reducing atherosclerosis
10/23/2008WO2008127179A1 Fusion protein vaccine
10/23/2008WO2008127102A1 S. pnuemoniae transcytosis protein
10/23/2008WO2008127099A1 Prevention of staphylococcus biofilm formation
10/23/2008WO2008126517A1 Novel slc17-type transporter protein in mammal and use thereof
10/23/2008WO2008126413A1 Tem8 peptides and vaccines comprising the same
10/23/2008WO2008126065A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/23/2008WO2008125985A2 Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
10/23/2008WO2008125983A2 Methods of increasing plant growth
10/23/2008WO2008125972A2 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
10/23/2008WO2008125816A1 Modulation of cellular proliferation
10/23/2008WO2008125635A1 Anti-tumor drug, medicament, composition, and use thereof
10/23/2008WO2008125433A1 Plant tissue with an altered content of a flavonoid component
10/23/2008WO2008125361A1 Method for the preparation of sulfated cellulose membranes and sulfated cellulose membranes
10/23/2008WO2008125119A1 Adaptive mutations allow establishment of jfh1-based cell culture systems for hepatitis c virus genotype 4a
10/23/2008WO2008125117A1 Cell culture system of a hepatitis c genotype 3a and 2a chimera
10/23/2008WO2008124934A1 Constructs for enhancement of gene expression in muscle
10/23/2008WO2008095168A3 Compositions and methods related to a recombinant adenoviral vector that targets il 13 receptors
10/23/2008WO2008093058A3 Peptides and their use
10/23/2008WO2008090332A3 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
10/23/2008WO2008087186A3 Peptides for use in the treatment of obesity
10/23/2008WO2008086386A3 Adenoviral vector-based malaria vaccines
10/23/2008WO2008074424A3 Coding genes with a single exon for new bioactive peptides
10/23/2008WO2008073877A3 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
10/23/2008WO2008073688A3 Improved expression system for recombinant human arginase i
10/23/2008WO2008070284A3 Amyloid beta peptides and methods of uses thereof
10/23/2008WO2008070276A3 Isolation op osteoinductive proteins
10/23/2008WO2008065372A3 Modified erythropoietin polypeptides and uses thereof for treatment
10/23/2008WO2008060785A9 Prevention of tissue ischemia, related methods and compositions
10/23/2008WO2008056346A3 Anti-angiogenic compounds
10/23/2008WO2008022015A3 Retro-inverso incretin analogues, and methods of use thereof
10/23/2008WO2008020330A9 Immunogens from uropathogenic escherichia coli
10/23/2008WO2008011204A3 Self-assembling protein hydrogel with bio-active protein
10/23/2008WO2008005375A3 Kidney toxicity biomarkers
10/23/2008WO2007143295A3 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
10/23/2008WO2007123680A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
10/23/2008WO2007108829A3 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
10/23/2008WO2007062422A3 Zinc finger binding domains for tnn
10/23/2008WO2007059190A3 Compositions of and methods of using stabilized psma dimers
10/23/2008WO2006066153A8 Actinomadura chromoprotein, apoprotein, and gene cluster
10/23/2008WO2005115341A3 Microparticles for oral delivery
10/23/2008WO2005065382A8 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
10/23/2008US20080263730 Nucleic acid molecules and other molecules associated with plants
10/23/2008US20080263728 Plastidial targeting peptide
10/23/2008US20080263726 Short vegetative phase (SVP) gene protein for enhancing flowering time in crop plants
10/23/2008US20080263725 expression of the nucleic acid sequence in the plant results in increased tolerance to environmental stress (drought, cold, oxidation)
10/23/2008US20080263690 Neuregulin-1 transgenic mouse and methods of use
10/23/2008US20080263687 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
10/23/2008US20080263683 Animal models expression receptors for advanced glycation end-products (RAGE) and inducible nitric oxide synthase for use as tool in identifying modulators for treatment and prevention of glomerular disorders
10/23/2008US20080262211 Hepatitis-c virus type 4, 5 and 6
10/23/2008US20080262206 Method of Isolating Proteon Nucleation Centers from Blood and Other Biological Materials
10/23/2008US20080262205 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease
10/23/2008US20080262202 Novel cancer-associated genes
10/23/2008US20080262198 Tyrosine modified protein for use in as components of crosslinked fibers, emulsifiers and moleclular scaffolds
10/23/2008US20080262197 Methods and materials for treating inflammatory conditions
10/23/2008US20080262087 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners
10/23/2008US20080261888 Platelet-derived growth factor-D (PDGF-D); stimulating cell proliferation, angiogensis
10/23/2008US20080261885 Conglycinin fragments extracted from ground, defatted soy, then precipitated by treatment with aqueous ethanol; metal affinity chromatography; treating with chymotrypsin; hyperlipidemia
10/23/2008US20080261883 Runx3 gene showing anti-tumor activity and use thereof
10/23/2008US20080261882 Methods for Inhibiting Heregulin and Treating Cancer
10/23/2008US20080261880 Synthetic approach to designed chemical structures
10/23/2008US20080261879 Activin (follistatin) receptors; inhibin; neuronal differentiation; transforming growth factors
10/23/2008US20080261878 In-vivo assay; tau protein; amyloid precursor proteins; neurodegenerative diseases
10/23/2008US20080261877 Albumin Fusion Proteins
10/23/2008US20080261876 Method for Purifying Marine Collagen and the Processing Thereof Into Porous Sponges
10/23/2008US20080261874 Point mutations; single or double alternation of tyrosine and aspartate residues; carcinoma; AIDS; gene therapy
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 2916